Across TCGA pan-cancer cohorts, CACNA1C-AS4 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of CACNA1C-AS4’s most consistent transcriptional readouts.
The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where CACNA1C-AS4 RNA is repressed in tumor relative to normal tissue. In most cancer types CACNA1C-AS4 is over-expressed in tumor, although a few such as UCEC and LUSC show the opposite, repressed pattern.
UCEC and LUSC are the cancer types where CACNA1C-AS4 tumor–normal differential expression is most reproducible.